ERLOZEST 150MG TABLET

About

Erlozest 150mg Tablet contains Erlotinib, a small molecule tyrosine kinase inhibitor that specifically targets the epidermal growth factor receptor (EGFR). It is primarily used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. By reversibly inhibiting the tyrosine kinase activity of EGFR, Erlotinib blocks the intracellular signaling pathways involved in cell growth, proliferation, and survival, which are often overactive in certain cancers. This targeted approach leads to tumor regression, particularly in patients with specific activating EGFR mutations.

Erlotinib represents a significant advancement in personalized cancer therapy, offering a more precise treatment option compared to traditional chemotherapy for eligible patients. It is administered orally and requires careful adherence to dosing instructions, including taking it on an empty stomach for optimal absorption. Patients are monitored for common side effects such as rash and diarrhea, as well as rare but serious pulmonary events. Its efficacy in improving progression-free survival has made it a cornerstone in the management of advanced NSCLC.

Uses

• Non-small cell lung cancer (NSCLC)
• Pancreatic cancer (in combination with gemcitabine)
• EGFR mutation-positive NSCLC
• Maintenance therapy for NSCLC

Directions For Use

Take this tablet orally once daily on an empty stomach, at least one hour before or two hours after food.

Benefits

• Targeted therapy for specific cancers
• Effective in EGFR mutation-positive NSCLC
• Improves progression-free survival
• Convenient oral administration
• Can be used as first-line or maintenance therapy
• Offers an alternative to traditional chemotherapy

Side Effects

• Rash (acneiform)
• Diarrhea
• Nausea and vomiting
• Fatigue
• Anorexia
• Dry skin
• Mouth sores (stomatitis)
• Conjunctivitis
• Interstitial lung disease (ILD) (rare but serious)
• Liver enzyme elevation
• Nail changes
• Hair thinning

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate gastrointestinal side effects.
• Pregnancy - Contraindicated during pregnancy as it can cause fetal harm. Use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as the drug may pass into breast milk and harm the infant.
• Liver - Use with caution; dosage adjustment may be necessary in patients with hepatic impairment.
• Kidney - Use with caution; no specific dosage adjustment usually needed for mild to moderate renal impairment.
• Lung - Monitor closely for new or worsening pulmonary symptoms due to the risk of interstitial lung disease.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.